144 related articles for article (PubMed ID: 16883003)
1. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
2. Correlation between metabolic uptake of F-18-FDG-PET/computed tomography and thyroglobulin level in differentiated thyroid cancer patients with suspected recurrence.
Askar HAA; Farghali RM; Mekkaway MA; Bashank NM
Nucl Med Commun; 2023 Jul; 44(7):640-645. PubMed ID: 37114410
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma.
Ha LN; Iravani A; Nhung NT; Hanh NTM; Hutomo F; Son MH
Cancer Imaging; 2021 Jan; 21(1):8. PubMed ID: 33413689
[TBL] [Abstract][Full Text] [Related]
4. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
5. Clinical role of 18F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer.
Tang X; Shi L; Zhao Z; Wang J; Yang R; Huang Y; Tang J; Chen Z; Wang F
Medicine (Baltimore); 2023 Jun; 102(24):e33878. PubMed ID: 37327310
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of 18F-FDG PET/CT in the follow-up of a large cohort of patients with high-risk differentiated thyroid carcinoma.
Yang JH; Maciel RMB; Nakabashi CCD; Janovsky CCPS; Padovani RP; Macellaro D; Camacho CP; Osawa A; Wagner J; Biscolla RPM
Arch Endocrinol Metab; 2017; 61(5):416-425. PubMed ID: 28977157
[TBL] [Abstract][Full Text] [Related]
7. Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies.
Frelau A; Palard-Novello X; Jali E; Boussemart L; Dupuy A; James P; Devillers A; Le Jeune F; Edeline J; Lesimple T; Girard A
Cancer Immunol Immunother; 2021 Mar; 70(3):679-687. PubMed ID: 32880684
[TBL] [Abstract][Full Text] [Related]
8. Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication.
Balogova S; Daraï E; Noskovicova L; Lukac L; Talbot JN; Montravers F
Clin Nucl Med; 2022 Apr; 47(4):305-313. PubMed ID: 35119396
[TBL] [Abstract][Full Text] [Related]
9. Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?
Sabbagh A; Jacobs C; Cooke R; Chu KY; Ng SM; Strauss VY; Virdee PS; Hawkins MA; Aznar MC; Muirhead R
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):72-80. PubMed ID: 30583927
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters.
Soyluoglu S; Tastekin E; Andac B; Korkmaz U; Orun SG; Durmus Altun G
Cureus; 2023 Sep; 15(9):e44751. PubMed ID: 37809246
[TBL] [Abstract][Full Text] [Related]
11. FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
Nourbakhsh S; Salehi Y; Farzanehfar S; Ghaletaki R; Bakhshi Kashi M; Abbasi M
Nuklearmedizin; 2024 Jan; ():. PubMed ID: 38190996
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of
Saponjski J; Macut D; Petrovic N; Ognjanovic S; Popovic B; Bukumiric Z; Sobic Saranovic D
Arch Med Sci; 2023; 19(6):1753-1759. PubMed ID: 38058718
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidism.
Chicklore S; Schulte KM; Talat N; Hubbard JG; O'Doherty M; Cook GJ
Clin Nucl Med; 2014 Mar; 39(3):237-42. PubMed ID: 24445273
[TBL] [Abstract][Full Text] [Related]
14. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview.
Treglia G; Annunziata S; Muoio B; Salvatori M; Ceriani L; Giovanella L
Int J Endocrinol; 2013; 2013():856189. PubMed ID: 23653645
[TBL] [Abstract][Full Text] [Related]
15. Left atrial metastasis of Hürthle-cell thyroid carcinoma mimicking myxoma.
Giovanella L; Treglia G; Ceriani L; Weidner S; Perriard U; Bongiovanni M
J Nucl Cardiol; 2014 Apr; 21(2):406-7. PubMed ID: 24263637
[No Abstract] [Full Text] [Related]
16. Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
Gimblet GR; Whitt J; Houson HA; Lin D; Guenter R; Rao TC; Wang D; Ness J; Gonzalez ML; Murphy MS; Gillis A; Chen H; Copland JA; Kenderian SS; Lloyd RV; Szkudlinski MW; Lapi SE; Jaskula-Sztul R
Surgery; 2024 Jan; 175(1):199-206. PubMed ID: 37919223
[TBL] [Abstract][Full Text] [Related]
17. Role of 18F-FDG PET/CT in the Follow-up of Colorectal Cancer.
Milardovic R; Beslic N; Sadija A; Ceric S; Bukvic M; Dzananovic L
Acta Inform Med; 2020 Jun; 28(2):119-123. PubMed ID: 32742064
[TBL] [Abstract][Full Text] [Related]
18. Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
Buchpiguel CA
Arch Endocrinol Metab; 2017 Oct; 61(5):411-413. PubMed ID: 29166452
[No Abstract] [Full Text] [Related]
19. The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma.
Lang BH
J Thyroid Res; 2012; 2012():198313. PubMed ID: 22007340
[TBL] [Abstract][Full Text] [Related]
20. Rare images of an intense 18F-FDG PET-scan uptake in an incidentally discovered thyroid lesion: A case report.
Miqdadi A; Ayach S; El Houari H; Cherkaoui Jaouad MR; Rami A; Boulmane H; Çaoui M
Radiol Case Rep; 2024 Apr; 19(4):1579-1581. PubMed ID: 38322235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
